Exercise Intervention as an Adjunct to Medical Therapy in Newly Diagnosed Patients With Pulmonary Arterial Hypertension

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGolden Jubilee National Hospital

About this trial

The goal of this clinical trial is to learn if an exercise programme started shortly after diagnosis improves the fitness and mental wellbeing of patients with pulmonary hypertenion over and above medication alone. It will also learn about whether extra support can help patients keep up with exercise in the long term. The main questions it aims to answer are:

* Doe exercise improve how far patients can walk over six minutes * Does exercise improve quality of life scores * Does exercise improve mental health scores * Does extra support after an exercise programme help patients to continue exercising in the long term

Researchers will compare the exercise programme to a control group (a group of similar patients who do not receive the exercise programme) to see the effect that exercise has.

Participants in the exercise programme group will:

* Undergo an exercise programme for 12 weeks, starting around 3 months after their diagnosis * They will undertake the exercise programme at home, remotely supervised by the research team with regular contact * Visit the clinic at the end of the programme for checkups and tests * Keep a diary of their exercise and how they are feeling

Participants in the control group will:

-Still undergo the exercise programme, but this will happen at a delayed time, starting around 6 months after diagnosis, to allow for a comparison between the two groups.

Following completion of the exerise programme:

* Half of participants will receive extra support to help them continue to exercise * The other half will not receive any additional support * All patients will be reviewed 1 year following the completion of their exercise programme to monitor their ongoing exercise levels.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18-years-old and above

a baseline mean pulmonary artery pressure >20mmHg

pulmonary vascular resistance >2 Wood Units

pulmonary capillary wedge pressure <15mmHg

Disqualifiers

Diagnosis with pulmonary hypertension of any other cause

Group II (PH due to left heart disease)

Group III (PH due to hypoxic lung disease)

Operable group IV (PH due to chronic thromboembolic disease amenable to surgical treatment)

Trial design

Design model

Crossover

Treatments tested in this trial

  • Home-based, remotely delivered, supervised Exercise programme

    Other intervention

    A home-based remotely delivered supervised exercise programme

Treatment groups

40 Participants
are divided into 4 treatment groups
Group A: Exercise Intervention Group then Adherence package group during follow-up phaseExperimental treatment 1 intervention
Group B: Exercise Intervention Group then control group during follow-up phaseExperimental treatment 1 intervention
Group C: Control group, then the Adherence package group during the follow-up phaseNo intervention 0 interventions
Group D: Control group, then also randomised to the control group in the follow-up phaseNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Six-minute walk distance

Distance walked as measured during a six-minute walk test. Measured at around 6 months post-diagnosis to compare those from the exercise intervention group who have just completed their exercise programme, with the control group who have not yet had their exercise programme.

Time frame
Around 6 months post diagnosis. (After completion of the exercise programme for those in the intervention group, and on medical therapy alone for those in the control group).

Secondary outcomes

1

EmPHasis-10 questionnaire

EmPHasis-10 quality of life questionnaire. Minimum value 0, Maximum value 50. Higher scores mean a worse outcome.

Time frame
Around 6 months post diagnosis. (After completion of the exercise programme for those in the intervention group, and on medical therapy alone for those in the control group).
2

NT-proBNP blood test

NTproBNP blood test which is a marker of cardiac strain

Time frame
Around 6 months post diagnosis. (After completion of the exercise programme for those in the intervention group, and on medical therapy alone for those in the control group).
3

Patient Health Questionnaire-9

Questionnaire validated for evaluating depression- completed by patients. Minimum value 0, Maximum value 27. Higher values indicated a worse outcome.

Time frame
Around 6 months post diagnosis. (After completion of the exercise programme for those in the intervention group, and on medical therapy alone for those in the control group).
4

Generalised Anxiety Disorder 7-item Scale

Questionnaire validated for evaluating anxiety in patients- completed by patients. Minumum value 0, Maximum value 21. Higher scores indicate a worse outcome.

Time frame
Around 6 months post diagnosis. (After completion of the exercise programme for those in the intervention group, and on medical therapy alone for those in the control group).

Other outcomes

1

Exercise adherence rating scale

Questionnaire validated for evaluating adherence to exercise in patients. Completed by patients. Minimum score 0, Maximum score 24. A higher score indicates better adherence.

Time frame
This will be collected after patients complete the exercise programme and again at the end of their follow-up phase. For patients randomised to Study Group 1, this is at week 37 and week 89 from enrolment. For Study group 2, this is week 25 and week 77.
2

Heart rate variability

Variation in time between consecutive heart beats, collected by a smartwatch. Measured in milliseconds. Higher heart rate variability means better fitness and recovery.

Time frame
This will be recorded during recorded sessions by the participant throughout study completion which is on average 83 weeks.
3

Exercise Frequency

Average number of recorded exercise sessions per week, measured as an absolute number. Higher number means more regular exercise.

Time frame
This will be recorded during recorded sessions by the participant throughout study completion which is on average 83 weeks.
4

Exercise Intensity

Exercise intensity is recorded by the participant using a smartwatch during recorded exercise sessions. Exercise intensity is measured by the heart rate during exercise expressed as a percentage of the estimated maximum heart rate. The measure will be recorded as time spent in particular heart rate zones, expressed in hours and minutes. Zone 1: 50-60% of maximum heart rate. Zone 2: 60-70% of maximum heart rate. Zone 3: 70-80% of maximum heart rate. Zone 4: 80-90% of maximum heart rate. Zone 5: 90-100% of maximum heart rate. Longer time spent in higher heart rate zones means higher intensity exercise.

Time frame
This will be recorded during recorded sessions by the participant throughout study completion which is on average 83 weeks.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Golden Jubilee National Hospital

Lead sponsor

Chiesi Farmaceutici S.p.A.

Collaborator

University of Glasgow

Collaborator